Novo Nordisk A/S (CPH:NOVO.B)
388.90
+23.70 (6.49%)
Jan 16, 2026, 4:59 PM CET
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
4.02M DKK
Profits / Employee
1.32M DKK
Market Cap
1.73T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Demant | 22,639 |
| Coloplast | 16,744 |
| GN Store Nord | 7,347 |
| H. Lundbeck | 5,707 |
| Ambu A/S | 5,384 |
| Embla Medical | 4,061 |
| ALK-Abelló | 2,753 |
| Genmab | 2,682 |
Novo Nordisk News
- 9 hours ago - European Stocks Post Fifth Weekly Advance; Novo Nordisk Rises - Financial Post
- 9 hours ago - Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? - Nasdaq
- 10 hours ago - Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? - The Motley Fool
- 10 hours ago - Trump's Greenland ambition: stocks that may face tariff shock in 2026 - Invezz
- 10 hours ago - Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data - Benzinga
- 10 hours ago - Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data - Benzinga
- 11 hours ago - Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more - CNBC
- 11 hours ago - Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch - CNBC